S. Morant

First name

S.

Middle name

V.

Last name

Morant

MacDonald, T. M., Morant, S. V., Goldstein, J. L., Burke, T. A., & Pettitt, D. (2003). Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut.

View

Morant, S. V., Pettitt, D., MacDonald, T. M., Burke, T. A., & Goldstein, J. L. (2004). Application of a propensity score to adjust for channelling bias with NSAIDs. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.946

View

MacDonald, T. M., Morant, S. V., & Mozaffari, E. (2007). Drug treatment discontinuation and achievement of target blood pressure and cholesterol in United Kingdom primary care. Curr Med Res Opin. http://doi.org/10.1185/030079907x233124

View

Hall, G. C., Morant, S. V., Carroll, D., Gabriel, Z. L., & McQuay, H. J. (2013). An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population. BMC Fam Pract. http://doi.org/10.1186/1471-2296-14-28

View

Mackenzie, I. S., Morant, S. V., Bloomfield, G. A., MacDonald, T. M., & O\textquoterightRiordan, J. (2014). Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry. http://doi.org/10.1136/jnnp-2013-305450

View

Mackenzie, I. S., Morant, S. V., Wei, L., Thompson, A. M., & MacDonald, T. M. (2017). Spironolactone use and risk of incident cancers: a retrospective, matched cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13152

View